ARS Pharmaceuticals, Inc. (SPRY) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 1.15B |
| Enterprise Value | 1.2B |
| P/E Ratio | -4.97 |
| PEG Ratio | 0.05 |
| Price/Sales Ratio | 10.01 |
| Price/Book Ratio | 16.16 |
| Enterprise/Revenue | 10.74 |
| Enterprise/EBITDA | -5.53 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -2 |
| Operating Margin | -2.04 |
AD
Management Effectiveness
| Return On Assets | -0.69 |
| Return On Equity | -1.54 |
Income Statement
| Revenue | 84.28M |
| Revenue/Share | 1 |
| Gross Profit | 63.86M |
| EBITDA | -167.41M |
| Net Income | -171.3M |
| Diluted EPS | -1.74 |
Balance Sheet
| Total Cash | 200.97M |
| Total Cash/Share | 2.02 |
| Total Debt | 96.52M |
| Total Debt/Equity | 1.57 |
| Current Ratio | 4.94 |
| Book Value Per Share | 0.62 |
Price History
| 52-Week Change | -39.77 |
| 52-Week High | 18.9 |
| 52-Week Low | 6.66 |
| Moving Average 50 Days | 8.56 |
| Moving Average 200 Days | 9.38 |
Statistics
| Average Volume | 1.66M |
| Shares Outstanding | 99.3M |
| % Held by Institutions | 94.89 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
